130 related articles for article (PubMed ID: 5812585)
41. [Effect of acute alcohol intoxication on the hematopoietic system].
Budzyński W; Krakiewicz A; Gola A
Pol Tyg Lek; 1976 Dec; 31(50):2131-2. PubMed ID: 1005195
[No Abstract] [Full Text] [Related]
42. [Current trends in the chemotherapy of cancer].
Silva-Sosa M
Gac Med Mex; 1974 May; 107(5):469-87. PubMed ID: 4602758
[No Abstract] [Full Text] [Related]
43. Treatment of cancer with weekly intravenous 5-fluorouracil. Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG).
Jacobs EM; Reeves WJ; Wood DA; Pugh R; Braunwald J; Bateman JR
Cancer; 1971 Jun; 27(6):1302-5. PubMed ID: 5088208
[No Abstract] [Full Text] [Related]
44. Hexamethylmelamine: an evaluation of its role in the treatment of ovarian cancer.
Wharton JT; Rutledge F; Smith JP; Herson J; Hodge MP
Am J Obstet Gynecol; 1979 Apr; 133(7):833-44. PubMed ID: 219695
[TBL] [Abstract][Full Text] [Related]
45. Is toxicity really necessary? II. Source and analysis of data.
Bross ID; Rimm AA; Slack NH; Ausman RK; Jones R
Cancer; 1966 Dec; 19(12):1785-95. PubMed ID: 5927938
[No Abstract] [Full Text] [Related]
46. [Present state and perspectives concerning the medical treatment of cancer].
Vermel' EM
Vopr Onkol; 1969; 15(1):92-104. PubMed ID: 4185056
[No Abstract] [Full Text] [Related]
47. Hexamethylmelamine in alkylating agent-resistant ovarian carcinoma.
Johnson BL; Fisher RI; Bender RA; DeVita VT; Chabner BA; Young RC
Cancer; 1978 Nov; 42(5):2157-61. PubMed ID: 102417
[TBL] [Abstract][Full Text] [Related]
48. Phase II trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study.
Forastiere AA; Budman DR; Richards F; Aisner J; Weinberg V; Wood WC
Cancer Treat Rep; 1983 Dec; 67(12):1137-8. PubMed ID: 6580949
[No Abstract] [Full Text] [Related]
49. Clinical phase I trial of inosine dialdehyde (NSC-118994).
Kaufman J; Mittelman A
Cancer Chemother Rep; 1975; 59(5):1007-14. PubMed ID: 1106841
[TBL] [Abstract][Full Text] [Related]
50. Hematologic aspects oa alcoholism.
Straus DJ
Semin Hematol; 1973 Jul; 10(3):183-94. PubMed ID: 4577644
[No Abstract] [Full Text] [Related]
51. Phase II evaluation of mitozolomide in ovarian cancer.
Harding M; Northcott D; Smyth J; Stuart NS; Green JA; Newlands E
Br J Cancer; 1988 Jan; 57(1):113-4. PubMed ID: 3348943
[No Abstract] [Full Text] [Related]
52. Combination chemotherapy with or without hexamethylmelamine in alkylating-agent resistant ovarian carcinoma.
Neijt JP; ten Bokkel Huinink WW; van der Burg ME; van Oosterom AT; Kooyman CD; van Houwelingen JC; Pinedo HM
Cancer; 1984 Apr; 53(7):1467-72. PubMed ID: 6421472
[TBL] [Abstract][Full Text] [Related]
53. [Peripheral blood picture in women treated with cytostatic for malignant tumors of the ovary].
Czarkwiani L; Misiewicz L
Ginekol Pol; 1966 May; 37(5):525-9. PubMed ID: 5911706
[No Abstract] [Full Text] [Related]
54. [A phase I trial of 4'-epiadriamycin].
Ogawa M; Ikeda K; Inagaki J; Horikoshi N; Inoue K; Nakada K; Usui N; Okada Y; Adachi K; Tada A
Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111
[TBL] [Abstract][Full Text] [Related]
55. Oxyphenbutazone (Tanderil) and blood dyscrasia.
Brownlie BE; Strang PJ
N Z Med J; 1969 Feb; 69(441):77-9. PubMed ID: 5252205
[No Abstract] [Full Text] [Related]
56. 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given alone and combined with antimetabolites in the treatment of advanced solid tumors.
Cohen SM; Weiner MJ; Greenspan EM
Cancer Chemother Rep; 1972 Dec; 56(6):751-4. PubMed ID: 4660631
[No Abstract] [Full Text] [Related]
57. [Toxic reactions during treatment of the ovarian cancer with ThioTEPA].
Shuvaeva NI; Emel'ianova LS
Akush Ginekol (Mosk); 1974 Oct; (10):18-20. PubMed ID: 4216276
[No Abstract] [Full Text] [Related]
58. [Cases of drug-induced blood disorders in Chugoku district].
Hino N
Rinsho Ketsueki; 1991 Jul; 32(7):714-7. PubMed ID: 1920832
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of the combination of hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in carcinoma of the lung.
Weiss AJ; Wilson WL
Cancer Chemother Rep; 1971 Jun; 55(3):299-302. PubMed ID: 5115850
[No Abstract] [Full Text] [Related]
60. Leukemia after treatment of ovarian cancer with alkylating agents.
Parker LM
N Engl J Med; 1983 Jun; 308(23):1422. PubMed ID: 6843637
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
